Abstract
<h3>Watch the video or read the poster to learn:</h3> <ul class="focus-visible" data-focus-visible-added=""><li data-stringify-indent="0" data-stringify-border="0">An electroporation platform for efficient, non-viral large-scale transfection for cell and gene therapy applications</li><li data-stringify-indent="0" data-stringify-border="0">How Nucleofector(R) technology can be applied at scales from 10,000 to 1 billion cells</li><li> </li><li data-stringify-indent="0" data-stringify-border="0">Five key considerations for success in genetic modification for cell therapy</li></ul><div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://cdn.insights.bio/uploads/Timo-Gleissner_Lonza copy.jpg" data-image="1"></div><div class="author-det"> <b>Timo Gleissner</b> is Associate Director Engineering within Bioscience Solutions at Lonza Cologne GmbH and responsible for the technical development of Lonza’s Nucleofector<sup>®️</sup> Transfection Platforms. In his current role Timo lead the development of the 4D-Nucleofector<sup>®️</sup> LV Unit for large-scale transfection and had the technical responsibility for the product design of the 21CFR part 11 compliant software as well as the TheraPEAK<sup>®️</sup> Consumables for GMP manufacturing. </div></div></div><div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://cdn.insights.bio/uploads/Andrea-Toell copy.jpg" data-image="1"></div><div class="author-det"> <b>Andrea Toell</b> is a Senior Product Manager at Lonza Cologne GmbH and is responsible for Lonza’s Nucleofector<sup>®️</sup> Transfection Portfolio. In her current role she is focusing on large volume transfection and cell and gene therapy applications (CAR-T cells, genome editing, GMP manufacturing). In her 20 years’ experience with the technology she gained a broad knowledge about transfection technologies and factors that are important for successful transfection experiments. </div></div></div>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
